National Foundation for Cancer Research Endorses ONDROX(TM)
Multiantioxidant Dietary Supplement Destroys Free Radicals Known to Cause
Cancer and Other Diseases in Humans
BETHESDA, Md., June 3 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced it has endorsed the multivitamin and dietary supplement ONDROX(TM), manufactured by LSI America Corporation in Austin, Texas as part of its ongoing initiative to prevent and cure cancer through basic science. The core formulation of ONDROX(TM) was originally developed at the M.D. Anderson Cancer Center, University of Texas. Its combination of multiple antioxidants has been shown to be highly effective in destroying free radicals and is the first such formulation designed on a time-release basis. Free radicals are associated with oxidative damage to DNA, which has been attributed to enhanced incidence rates of cancer and other immunological and cardiovascular disorders in humans. It has also been shown that unbalanced diets account for about one-third of cancer risk. Micronutrients, whose main dietary sources are other than fruits and vegetables, are likely to play a significant role in the prevention and repair of DNA damage. Basic science research supported by NFCR has shown how important micronutrients are in the defense against oxidative DNA damage and the maintenance of long-term health. Several NFCR project directors have been exploring the role of antioxidants in diet, aging and the risk of cancer. "We believe this initiative helps to bring medical discoveries from basic science research to the public," said NFCR president, Franklin Salisbury, Jr. Founded in 1973, NFCR is dedicated to understanding how cancer develops and finding a cure. With NFCR's support, scientists in all disciplines all over the world conduct basic science cancer research at the molecular and submolecular levels. NFCR encourages and facilitates cooperation and the sharing of ideas and results, enabling advances in one field to lead to progress across other fields in cancer research. NFCR calls this cooperation the "Laboratory Without Walls." For further information about the National Foundation for Cancer Research, please call (800) 321-CURE or visit the web site at www.NFCR.org . LSI America Corporation is the parent holding company for LifeScience Corporation and is engaged in the commercialization of leading edge pharmaceutical products suitable for over the counter distribution. ONDROX(TM) is manufactured at the facilities of Biotics Research corporation in Houston, Texas. The Biotics plant is FDA approved and inspected, and complies with standards exceeding those required for the production of dietary supplements. For further information about LSI America Corporation and ONDROX(TM), please call (888) 5-ONDROX or (800) 720-5936 and visit the web site at www.ONDROX.com .
SOURCE The National Foundation for Cancer Research
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.